BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34119324)

  • 21. Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.
    Dumesic DA; Phan JD; Leung KL; Grogan TR; Ding X; Li X; Hoyos LR; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2171-2183. PubMed ID: 30649347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
    Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome.
    Carmina E; Chu MC; Moran C; Tortoriello D; Vardhana P; Tena G; Preciado R; Lobo R
    Fertil Steril; 2008 Mar; 89(3):642-8. PubMed ID: 17562334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome.
    González F; Sia CL; Shepard MK; Rote NS; Minium J
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4071-9. PubMed ID: 22904174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
    Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
    J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).
    Barrea L; Arnone A; Annunziata G; Muscogiuri G; Laudisio D; Salzano C; Pugliese G; Colao A; Savastano S
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
    Patlolla S; Vaikkakara S; Sachan A; Venkatanarasu A; Bachimanchi B; Bitla A; Settipalli S; Pathiputturu S; Sugali RN; Chiri S
    Gynecol Endocrinol; 2018 Mar; 34(3):238-242. PubMed ID: 29068242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.
    Chen L; Xu WM; Zhang D
    Fertil Steril; 2014 Oct; 102(4):1167-1174.e4. PubMed ID: 25064406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
    Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome.
    Demi R İ; Guler A; Alarslan P; Isil AM; Ucman O; Aslanipour B; Calan M
    Endocrine; 2019 Jul; 65(1):175-183. PubMed ID: 31154608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.